Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.
Publication
, Journal Article
Levy, WC; Lee, KL; Hellkamp, AS; Poole, JE; Mozaffarian, D; Linker, DT; Maggioni, AP; Anand, I; Poole-Wilson, PA; Fishbein, DP; Johnson, G ...
Published in: Circulation
September 8, 2009
BACKGROUND: Although implantable cardioverter-defibrillator (ICD) therapy reduces mortality in moderately symptomatic heart failure patients with an ejection fraction
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
September 8, 2009
Volume
120
Issue
10
Start / End Page
835 / 842
Location
United States
Related Subject Headings
- Risk
- Primary Prevention
- Models, Statistical
- Middle Aged
- Male
- Kaplan-Meier Estimate
- Humans
- Heart Failure
- Female
- Defibrillators, Implantable
Citation
APA
Chicago
ICMJE
MLA
NLM
Levy, W. C., Lee, K. L., Hellkamp, A. S., Poole, J. E., Mozaffarian, D., Linker, D. T., … Bardy, G. H. (2009). Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation, 120(10), 835–842. https://doi.org/10.1161/CIRCULATIONAHA.108.816884
Levy, Wayne C., Kerry L. Lee, Anne S. Hellkamp, Jeanne E. Poole, Dariush Mozaffarian, David T. Linker, Aldo P. Maggioni, et al. “Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.” Circulation 120, no. 10 (September 8, 2009): 835–42. https://doi.org/10.1161/CIRCULATIONAHA.108.816884.
Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, et al. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation. 2009 Sep 8;120(10):835–42.
Levy, Wayne C., et al. “Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.” Circulation, vol. 120, no. 10, Sept. 2009, pp. 835–42. Pubmed, doi:10.1161/CIRCULATIONAHA.108.816884.
Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, Maggioni AP, Anand I, Poole-Wilson PA, Fishbein DP, Johnson G, Anderson J, Mark DB, Bardy GH. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation. 2009 Sep 8;120(10):835–842.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
September 8, 2009
Volume
120
Issue
10
Start / End Page
835 / 842
Location
United States
Related Subject Headings
- Risk
- Primary Prevention
- Models, Statistical
- Middle Aged
- Male
- Kaplan-Meier Estimate
- Humans
- Heart Failure
- Female
- Defibrillators, Implantable